FiBioMed

We are cutting-edge Health Tech company specializing in connecting vast molecular biology with novel photonics technologies, chemistry & biomedical engineering to create biosensing solutions that can revolutionize infectious diseases in-vitro diagnostics. We discover, develop and commercialize disruptive diagnostics and monitoring tools on a global scale and create lifesaving innovations which can help medical professionals in real-time diagnosis and monitoring. FIBIOMED SPÓŁKA z o.o. (LLC) is undertaking the project titled: "Development and testing of an innovative technology to cultivate specific antibodies, and a device for fast diagnostics of viruses (including SARS-Cov-2) that can be implemented in the diagnostics, treatment and prevention during states of epidemiological emergency, as part of Measure 1.1 “R+D Projects of Enterprises” and Sub-Measure 1.1.1 “Industrial Research and Development Works Conducted by Enterprises” The objective of the project is to develop, test and implement an innovative partly automated device for high-throughput analysis of samples for SARS-CoV-2 that can be easily and quickly adapted to the analysis of other pathogens or diagnostic markers. Project value: PLN 12,327,736.88 Contribution of European Funds: PLN 10,046,456.53